AVII

AVI BioPharmaInc. on friday announced results on it's Neugene Antisense Technology to cobat Ebola and Marburg viruses to be effective. Also effective in fighting Racin and Anthrax toxins. The company also announced it will test this technology in the Avian Flu strain H5Ni. These test were funded partially by the Dept. of Defense. Keep this stock on the trading radar it is trading up in pre market this morning.

Budd Foxx